ClinicalTrials HQ

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

Active, not recruiting · NCT04404595 · Registry updated 2025-01-08
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive CancersDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, endocrine system disorder, gastric cancer, gastric neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, stomach disorderActive, not recruitingPhase 1 / Phase 22025-01-08NCT04404595

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
CARsgen Therapeutics Co., Ltd.20

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Froedtert Hospital and the Medical College of WisconsinMilwaukeeUnited States27
Karmanos Cancer CenterDetroitUnited States16
Mayo Cancer HospitalRochesterUnited States1
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Moffitt Cancer CenterTampaUnited States523
Northwell Cancer InstituteNew Hyde ParkUnited States1
Ohio State UniversityColumbusUnited States169
Princess Margaret HospitalTorontoCanada1
The Mount Sinai HospitalNew YorkUnited States36
TX Oncology-Baylor Charles Sammons Cancer CenterDallasUnited States1
UCSDSan DiegoUnited States2
UCSFSan FranciscoUnited States27
University of Kansas Cancer CenterKansas CityUnited States242
University of Southern CaliforniaLos AngelesUnited States25